IktosAI
@IktosAI
Followers
1K
Following
264
Media
33
Statuses
247
Artificial intelligence for new drug design
Paris, France
Joined April 2018
Come see @Iktos present 4/25 at @MassBio 2024 Align Summit w/ insights by @McKinsey & @LocustWalkPtrs. Register here: https://t.co/7yLmTocv7q
#AlignSummit24
0
0
1
@IktosAI and @ElsLifeSciences are thrilled to partner together to deliver a predictive #retrosynthesis and synthetic accessibility platform that accelerates chemistry research for drug discovery. Learn more: https://t.co/aecXuKSeDY
#Reaxys #drugdiscovery #DMTAcycle #AI
1
0
2
In an interview with PharmaShots, Dr. Sree Vadlamudi, Vice president, Head of Business Development EU and RoW at @IktosAI, shared his views on the role of AI in shaping the pharma & biotech industry. Read the interview here: https://t.co/Swl9PmSjUr
https://t.co/l7QDnxCCAl
linkedin.com
In an interview with PharmaShots, Dr. Sree Vadlamudi, Vice President, Head of Business Development EU and RoW at Iktos, shared his views on the role of AI in shaping the pharma & biotech industry....
1
2
2
Dr. Sree Vadlamudi Vadlamudi, Vice President, Head of BD- EU & RoW, Iktos, talks about ‘Using AI to foster productivity in pharmaceutical research and development’ in a blog published as a part of SLAS Europe 2022 coverage. https://t.co/IpVPnlf0jE
linkedin.com
Dr. Sree Vadlamudi Vadlamudi, Vice President, Head of BD- EU & RoW, Iktos, talks about ‘Using AI to foster productivity in pharmaceutical research and development’ in a blog published as a part of...
0
1
1
Our CEO & Co-Founder, Yann Gaston-Mathe's interview on Spaya™ has been published by Medicen in their 2022 report. Follow the link for the full report: https://t.co/ytXpHvxlVN
https://t.co/LwektfCOSS
linkedin.com
Our CEO & Co-Founder, Yann Gaston-Mathe's interview on Spaya™ has been published by Medicen in their 2022 report. Follow the link for the full report: https://lnkd.in/eMScxFA6 Iktos, Makya™, Spaya™...
0
1
1
@IktosAI announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development. https://t.co/3a9cjHWWSD
linkedin.com
Iktos announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development. Under this...
0
1
1
@IktosAI announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development. https://t.co/3a9cjHWWSD
linkedin.com
Iktos announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development. Under this...
0
3
2
@IktosAI team is thrilled to announce their latest collaboration agreement with Galapagos Iktos, Makya™, Spaya™ https://t.co/eomXOee2mM
0
2
2
@IktosAI team is very pleased to share the news about our latest collaboration agreement with Zealand Pharma pharma to develop AI technology for peptide drug design https://t.co/mDY7U5olHh
linkedin.com
Iktos team is thrilled to announce their latest collaboration agreement with Zealand Pharma to develop AI technology for peptide drug design. Iktos, a company specialized in Artificial Intelligence...
0
1
3
Interested to know more about Makya? Have a look at out new site https://t.co/dgHv67geGR
@IktosAI , Makya™, Spaya™ https://t.co/RlntbLIBl3
iktos.ai
0
1
1